NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055414

Registered date:17/09/2024

Fatigue Improvement Intervention Study

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedNot applicable
Date of first enrollment2024/09/17
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Perform light exercise for 30 minutes per day, 5 weekdays (Monday upon waking to Friday upon waking)-Extending the average time in bed by 1.2 times per day for 5 weekdays (from Monday waking time to Friday waking time) Extending the average time in bed by 1.2 times per day for 5 weekdays (from Monday waking time to Friday waking time)-Perform light exercise for 30 minutes per day, 5 weekdays (Monday upon waking to Friday upon waking)

Outcome(s)

Primary OutcomeRelationship between the amount of change in waking fatigue before and after the intervention and baseline measurement data
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum59years-old
GenderMale and Female
Include criteria
Exclude criteria1. Person who currently suffers from chronic diseases (diabetes, hypertension, hyperlipidemia, gout, renal disease, rheumatic or respiratory disease, etc.) and are taking medication (however, users of drugs to control allergic symptoms such as allergic rhinitis shall be included in the target population). 2. Person who is unable to participate in the study due to liver, renal, cardiac, respiratory, endocrine, metabolic, neurological, consciousness, diabetes, or other diseases. 3. Patient with insomnia, sleep apnea syndrome, or other sleep disorders. 4. Patient with chronic fatigue syndrome 5. Patient taking sleeping pills 6. Person who drinks a lot of alcohol (alcohol equivalent of 60g/day or more: (beer: 3 medium bottles (1.5L), sake: 3 gou (540ml), whiskey: 3 double drinks (180ml), shochu: 1.8 gou (330ml) or more). 7. Patient with skin diseases (atopic dermatitis, acne vulgaris, psoriasis, etc.) on the face. 8. Person who uses topical medical products on the face. 9. Patient with excessive sunburn on the face. 10. Person who is currently participating in other human clinical trials or have participated in other drug or food trials within the past month or are planning to participate in other trials in the future during the period of this study. 11. Person who is not on a day shift, such as night work or rotating shifts. 12. Person who is currently pregnant or wish to become pregnant during the study participation period. 13. Person with a history or current history of drug or alcohol dependence. 14. Person who is planning to travel, go on business, or go on vacation during the measurement period. 15. Person who does not own a smart phone and is unable to complete the questionnaire via an app or web browser. 16. Person who is deemed inappropriate for the study by the principal investigator.

Related Information

Contact

public contact
Name Keita Kinoshita
Address 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN 131-8501
Telephone +81-3-5630-7268
E-mail sugitani.kei@kao.com
Affiliation Kao Corporation Human Health Care Products Research Lab.
scientific contact
Name Masanobu Hibi
Address 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN
Telephone +81-3-5630-7268
E-mail hibi.masanobu@kao.com
Affiliation Kao Corporation Human Health Care Products Research Lab.